Graves’ Disease Clinical Trials Near Me
As of October 12, 2026, 41 Graves’ Disease clinical trials are recruiting or about to open (34 recruiting now, 7 opening soon). 14 of them have at least 1 open site in the United States, across 33 states. Enter your ZIP code to see which are closest to you.
Also on Trial Friend:Graves’ Disease pageMatch Me
All 34 Graves’ Disease trials and their US sites
Enter your ZIP code above to sort them by how far their nearest open site is from you.
- A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease55 open sitesRecruitingPhase 2Ages 18 to 75Run by Immunovant Sciences GmbH
- Study to Determine if BHV-1300 is Effective and Safe in Adults With Graves' Disease51 open sitesRecruitingPhase 3Ages 18 to 70Run by Biohaven Therapeutics Ltd.
- A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease33 open sitesRecruitingPhase 2Ages 18 to 75Run by Immunovant Sciences GmbH
- Evaluation of YB-101 for Safety, Tolerability, Pharmacokinetics, and Efficacy in Graves' Disease27 open sitesRecruitingPhase 2Ages 18+Run by Yarrow Bioscience, Inc.
- A Study to Assess Efficacy and Safety of Efgartigimod PH20 SC PFS in Adult Participants With Graves' DiseaseDiabetes Associates Medical Group, Orange, California; Havana Research Institute LLC., Pasadena, California; Northeast Florida Endocrine & Diabetes Associates (NEFEDA) - Orange Park Location, Fleming Island, Florida and 18 more sitesRecruitingPhase 3Ages 18+Run by argenx
- NEXUS Study: A Study to Test Single and Multiple Doses of MER511 Given to Adults With Graves' Disease11 open sitesRecruitingPhase 1Ages 18 to 65Run by Merida Biosciences
- Study of BHV-1300 in Graves' Disease10 open sitesRecruitingPhase 1Ages 18 to 65Run by Biohaven Therapeutics Ltd.
- A Study to Learn About The Effects of Felzartamab on Thyroid Function and Its Safety in Adults With Graves' Disease Ages 18 to 75 Years OldSun City Clinical Research, Glendale, Arizona; AME Clinical Research, Los Angeles, California; DM Clinical Research, Doral, Florida and 6 more sitesRecruitingPhase 2Ages 18 to 75Run by Biogen
- Preoperative Corticosteroids in Autoimmune Thyroid DiseaseIU Health North Hospital, Indianapolis, Indiana; IU Health Methodist Hospital, Indianapolis, Indiana; IU Health University Hospital, Indianapolis, IndianaRecruitingPhase 4Ages 18+Run by Indiana University
- Evaluating an AI Tool for Detecting Thyrotoxic StatesUmesh Masharani, San Francisco, CaliforniaRecruitingAges 22+Run by THYROSCOPE INC.
- Impact of Vitamin D Therapy on Thyroid Function and Antibody Levels in Pediatric Graves' DiseasePediatric Endocrinology at Northwell Health, New Hyde Park, New YorkRecruitingPhase 2Ages 9 to 17Run by Northwell Health
- Personalized Treatment in Thyroid DisordersJohns Hopkins Hospital, Baltimore, MarylandRecruitingAges 21 to 65Run by Johns Hopkins University
- Telehealth Music Therapy for Adults With Endocrine Disorder and DepressionAppalachian State University, Boone, North CarolinaRecruitingAges 18 to 65Run by Appalachian State University
- The Effect of Teprotumumab on Thyroid Eye Disease and Thyroid DysfunctionWalter Reed National Military Medical Center, Bethesda, MarylandRecruitingAges 18+Run by Walter Reed National Military Medical Center
- A Clinical Follow-up Study on Drug Therapy for Graves' Disease Patients in ChinaNo open US site listed yetRecruitingAges 18+Run by First Hospital of China Medical University
- A Study of GensSci098 in Subjects With Graves' DiseaseNo open US site listed yetRecruitingPhase 1Ages 18+Run by Changchun GeneScience Pharmaceutical Co., Ltd.
- A Study to Assess Efficacy and Safety of Efgartigimod PH20 SC PFS in Adult Participants With Graves' Disease.No open US site listed yetRecruitingPhase 3Ages 18+Run by argenx
- A Study to Investigate the Efficacy and Safety of Rilzabrutinib in Adult Participants With Graves' DiseaseNo open US site listed yetRecruitingPhase 2Ages 18 to 75Run by Sanofi
- Allogeneic Anti-CD19 CAR-T for Refractory Graves' DiseaseNo open US site listed yetRecruitingEarly Phase 1Ages 18 to 65Run by Shanghai Zhongshan Hospital
- Allogeneic Anti-CD19/BCMA CAR-T for Refractory Graves' DiseaseNo open US site listed yetRecruitingEarly Phase 1Ages 18 to 75Run by Shanghai Zhongshan Hospital
New trials, status changes and new sites, straight from ClinicalTrials.gov. Unsubscribe anytime.
You'll get new recruiting trials, changes to trials, FDA decisions and condition news for Graves’ Disease. Turn any of these off from the link in every email.
Where Graves’ Disease trials are recruiting in the US
The US cities with the most Graves’ Disease trials recruiting are Dallas, Texas (7), Miami, Florida (7), Houston, Texas (6), Asheville, North Carolina (3) and Canton, Ohio (3), counting trials with at least 1 open site in each city.
Hospitals that run trials for a rare condition often see more people with it than most clinics do, so this list can also help you find doctors who know Graves’ Disease, even if no trial fits you.
- M3 Wake Research - Dallas
- Research Institute of Dallas
- Floridian Clinical Research - Clinitiative
- Oceane 7 Medical & Research Center, Inc
- Clinic of Endocrinology
- Juno Research
- Asheville Clinical Research
- DM Clinical Research
- Profound Research
States with at least 1 open site: Arizona, California, Colorado, Delaware, District of Columbia, Florida, Georgia, Illinois, Indiana, Kansas, Kentucky, Louisiana, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Nebraska, Nevada, New Jersey, New York, North Carolina, Ohio, Oklahoma, Oregon, Pennsylvania, South Carolina, Tennessee, Texas, Utah, Virginia, Washington.
Questions about finding a Graves’ Disease trial near you
Are there Graves’ Disease clinical trials near me?
As of October 12, 2026, 41 Graves’ Disease clinical trials are recruiting or about to open (34 recruiting now, 7 opening soon). 14 of them have at least 1 open site in the United States, across 33 states. Enter your ZIP code on this page to rank every one of them by the distance to its closest open site, with the sites shown on a map.
Which states have Graves’ Disease clinical trial sites?
As of October 12, 2026, recruiting Graves’ Disease trials list open sites in 33 states. The US cities with the most Graves’ Disease trials recruiting are Dallas, Texas (7), Miami, Florida (7), Houston, Texas (6), Asheville, North Carolina (3) and Canton, Ohio (3), counting trials with at least 1 open site in each city.
What if there is no Graves’ Disease trial near me?
Some trials pay for or reimburse travel and lodging, and a few send staff or use local labs so fewer visits happen at the study site, so ask the study contact before ruling a trial out. You can also sign up on this page to get an email when a Graves’ Disease trial opens a new site or changes status.
How is the distance to a trial site measured?
Distances are straight-line miles from the center of your ZIP code to each study site's listed location, not driving distance. Your browser looks up the ZIP code's coordinates with a free map service, Zippopotam.us, and the ZIP code is never sent to or stored by Trial Friend.
Source: ClinicalTrials.gov, trials with status Recruiting or Not yet recruiting. Refreshed every 6 hours; counts as of October 12, 2026. Sites that ClinicalTrials.gov lists as closed or withdrawn are left out.